Back to Search Start Over

Enanta's RSV antiviral crushes viral load in challenge study.

Authors :
Taylor, Nick Paul
Source :
FierceBiotech; 9/26/2024, pN.PAG-N.PAG, 1p
Publication Year :
2024

Abstract

Enanta said the data cleared the bar set by its other candidate, opening up opportunities to test the molecules as single agents and in combination. [ABSTRACT FROM AUTHOR]

Details

Language :
English
Database :
Complementary Index
Journal :
FierceBiotech
Publication Type :
Periodical
Accession number :
179973482